Human Reproduction, Vol. 8, No. 12, pp. 2080-2087, 1993
© 1993 European Society of Human Reproduction and Embryology
review-article |
Infertility: Ultrastructure of human ovarian primordial follicles after combination chemotherapy for Hodgkin's disease
1Departments of Anatomy, University of Rome ‘La Sapienza’ Via A.Borelli 50, 00161 Rome, Italy 2Departments of Gynaecology, University of Rome ‘La Sapienza’ Via A.Borelli 50, 00161 Rome, Italy
Correspondence: 3To whom correspondence should be addressed
Ovarian damage, with consequent permanent infertility, is one of the more common side-effects which occurs during chemotherapeutic treatment of patients affected by Hodgkin's disease. This damage is morphologically represented by a marked loss of primordial and primary follicles. The administration of contraceptive drugs before starting chemotherapy enhances survival of a greater number of ovarian follicles, as revealed by morphometric analyses, nevertheless, total ovarian protection is not assured. This study evaluated the number and the morphology of ovarian follicles, by means of transmission electron microscopy, in patients with Hodgkin's disease treated with multi-drug chemotherapeutic protocols following the administration of medroxyprogesterone acetate. Ovarian biopsies were performed prior to any pharmacological treatment, after medroxyprogesterone therapy, and after this therapy plus chemotherapy. Particular attention was given to the ultrastructure of primordial follicles. After morphometric evaluation, primordial follicles were numerous in controls and medroxyprogesterone therapy (28.55 ± 6.59/mm3 of ovarian cortex). After chemotherapy and medroxyprogesterone acetate, the number of follicles was slightly reduced (19.37 ± 3.41/mm3 of ovarian cortex) in contrast to the dramatic loss usually observed when protection is not given, although more follicles were atretic. Medroxyprogesterone may protect follicles only from acute, toxic effects of chemotherapy, which dramatically reduce their number and lead to sterility. Nevertheless, the quality of follicles is still impaired, and many undergo atresia, resulting in a shortened fertility period.
Key words: chemotherapy/Hodgkin's disease/ovarian follicle/ovary/ultrastructure
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  M. Sonmezer, H. Bang, and K. Oktay In Reply: Can GnRH Analogues Preserve Gonadal Function Without Preserving Fertility? Oncologist, May 1, 2008; 13(5): 615 - 617. [Full Text] [PDF]
|
|
|
|
 |
|
 R. Abir, A. Ben-Haroush, C. Felz, E. Okon, H. Raanani, R. Orvieto, S. Nitke, and B. Fisch Selection of patients before and after anticancer treatment for ovarian cryopreservation Hum. Reprod., April 1, 2008; 23(4): 869 - 877. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Oktay, M. Sonmezer, O. Oktem, K. Fox, G. Emons, and H. Bang Absence of Conclusive Evidence for the Safety and Efficacy of Gonadotropin-Releasing Hormone Analogue Treatment in Protecting Against Chemotherapy-Induced Gonadal Injury Oncologist, September 1, 2007; 12(9): 1055 - 1066. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. Oktay and O. Oktem Regeneration of Oocytes After Chemotherapy: Connecting the Evidence From Mouse to Human J. Clin. Oncol., August 1, 2007; 25(22): 3185 - 3187. [Full Text] [PDF]
|
|
|
|
|
|
D. Meirow, J. Dor, B. Kaufman, A. Shrim, J. Rabinovici, E. Schiff, H. Raanani, J. Levron, and E. Fridman Cortical fibrosis and blood-vessels damage in human ovaries exposed to chemotherapy. Potential mechanisms of ovarian injury Hum. Reprod., June 1, 2007; 22(6): 1626 - 1633. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M.-M. Dolmans, N. Michaux, A. Camboni, B. Martinez-Madrid, A. Van Langendonckt, S. Annarita Nottola, and J. Donnez Evaluation of Liberase, a purified enzyme blend, for the isolation of human primordial and primary ovarian follicles Hum. Reprod., February 1, 2006; 21(2): 413 - 420. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Behringer, K. Breuer, T. Reineke, M. May, L. Nogova, B. Klimm, T. Schmitz, L. Wildt, V. Diehl, and A. Engert Secondary Amenorrhea After Hodgkin's Lymphoma Is Influenced by Age at Treatment, Stage of Disease, Chemotherapy Regimen, and the Use of Oral Contraceptives During Therapy: A Report From the German Hodgkin's Lymphoma Study Group J. Clin. Oncol., October 20, 2005; 23(30): 7555 - 7564. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Sonmezer and K. Oktay Fertility preservation in female patients Hum. Reprod. Update, May 1, 2004; 10(3): 251 - 266. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. S. Letterie Anovulation in the prevention of cytotoxic-induced follicular attrition and ovarian failure Hum. Reprod., April 1, 2004; 19(4): 831 - 837. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. C. Zachos, R. B. Billiar, E. D. Albrecht, and G. J. Pepe Regulation of Oocyte Microvilli Development in the Baboon Fetal Ovary by Estrogen Endocrinology, February 1, 2004; 145(2): 959 - 966. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J.P. de Bruin, M. Dorland, E.R. Spek, G. Posthuma, M. van Haaften, C.W.N. Looman, and E.R. te Velde Ultrastructure of the Resting Ovarian Follicle Pool in Healthy Young Women Biol Reprod, April 1, 2002; 66(4): 1151 - 1160. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. C. Linch, R. G. Gosden, T. Tulandi, S.-L. Tan, and S. L. Hancock Hodgkin's Lymphoma: Choice of Therapy and Late Complications Hematology, January 1, 2000; 2000(1): 205 - 221. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. Meirow, H. Lewis, D. Nugent, and M. Epstein Subclinical depletion of primordial follicular reserve in mice treated with cyclophosphamide: clinical importance and proposed accurate investigative tool Hum. Reprod., July 1, 1999; 14(7): 1903 - 1907. [Abstract] [Full Text] [PDF]
|
|